CLL

patient care perspectives by Susan O’Brien, MD

Noncovalent BTK inhibitors (eg, pirtobrutinib) have generated promising data in the later-line treatment of chronic lymphocytic leukemia (CLL). Piv......READ MORE

Multiple Myeloma

patient care perspectives by Kenneth C. Anderson, MD

Chimeric antigen receptor (CAR) T-cell therapy has shown impressive responses in patients with heavily pretreated multiple myeloma. An open and tra......READ MORE

cGVHD

patient care perspectives by Robert S. Negrin, MD

Chronic graft-versus-host disease (cGVHD) may impact patient well-being in ways that are challenging to observe, and patient experiences vary widel......READ MORE

Multiple Myeloma

expert roundtables by Kenneth C. Anderson, MD; Sagar Lonial, MD, FACP; and S. Vincent Rajkumar, MD

While the ability to treat patients with highly refractory multiple myeloma is promising, a great need remains for novel agents and additional ther......READ MORE

HER2-Positive Breast Cancer

patient care perspectives by Sara M. Tolaney, MD, MPH

Individualizing therapy for patients with human epidermal growth factor receptor 2–positive (HER2+) breast cancer currently involves the considerat......READ MORE